CANOQ — Cano Health Income Statement
0.000.00%
- $1.30m
- -$112.75m
- $3.14bn
- 40
- 54
- 14
- 29
Annual income statement for Cano Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 361 | 832 | 1,609 | 2,739 | 3,138 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 371 | 855 | 1,758 | 3,177 | 4,142 |
Operating Profit | -9.69 | -23.5 | -148 | -438 | -1,004 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -19.8 | -70.4 | -117 | -426 | -1,101 |
Provision for Income Taxes | |||||
Net Income After Taxes | -19.8 | -71.1 | -117 | -428 | -1,099 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -19.8 | -71.1 | -18 | -207 | -594 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -19.8 | -71.1 | -18 | -207 | -594 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -11.9 | -33.6 | -5.57 | 1.42 | -107 |
Dividends per Share |